Although treatment of neuroblastoma cells with ABTL0812 resulted in increased TRIB3 levels and bi-lipidation of LC3, the levels of AKT phosphorylation or its downstream targets PRAS40 and S6 were not modified at the time and doses analysed (Fig. 3a, b). This evidence concerns the gene AKT1 and neuroblastoma.